Thomas C. Reynolds, Chief Medical Officer at SEATTLE GENETICS INC /WA (SGEN), sold 25,000 shares at $12.47 ($312K) on 2009-07-30, disclosed to the SEC on 2009-07-31.
Open-market sale of $312k SGEN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SGEN | SELL | 2013-01-17 | $3.5M | — | Filing → |
| SGEN | SELL | 2012-12-10 | $1.7M | — | Filing → |
| SGEN | SELL | 2012-12-06 | $1.0M | — | Filing → |